Peptides
Compounding pathways, sourcing standards, and the FDA classification landscape.
Medico-Legal News · US Regenerative
Loading latest headlines…
Regenerative Medicine Advisory · USA
Adopt regenerative medicine with confidence — and with the risk understood.
We help US clinics and practitioners safely and compliantly add emerging therapies—peptides, exosomes, and stem cells—through factual, risk-based advisory work spanning medico-legal, regulatory, and business risk.
Legal + Clinical LeadershipRisk-Based MethodologyUS Regulatory Focus
What We Do
Practical, risk-based advisory — not generic compliance templates.
Our work equips clinics and practitioners to introduce regenerative services with clear governance, documented protocols, and a defensible position under current US regulation.
See all services →Medico-legal & Regulatory Risk Reviews
Factual, risk-based reviews of your intended service line against the current US regulatory landscape.
Clinical Governance Structures
Governance frameworks that align clinical oversight, documentation, and accountability.
Policies, Procedures & Protocols
Practice-specific policies and treatment protocols grounded in evidence and defensible practice.
Supplier Vetting & Due Diligence
Structured due-diligence guidance for peptide, exosome, and stem cell suppliers.
Therapies We Cover
Framed around regulatory and governance considerations.
Exosomes
Current FDA position, marketing exposure, and documentation of consent and rationale.
Stem Cells
HCT/P framework, minimal manipulation, homologous use, and clinic-based risk factors.
Our Approach
Factual. Evidence-based. Risk-informed.
Every engagement combines legal analysis with clinical judgement. We draw on extensive experience delivering these services across multiple international jurisdictions, now applied to the US regulatory landscape.
How we work →- 01
Scope & Discovery
Understand the practice, intended therapies, and current position.
- 02
Risk Assessment
Structured medico-legal, regulatory, and business risk review.
- 03
Governance & Protocols
Draft policies, protocols, and consent frameworks.
- 04
Implementation Support
Training, supplier vetting, and ongoing advisory access.
Advisory Call
Bring a legal and clinical lens to your regenerative program.
Book a scoping call to discuss your practice, the therapies you're considering, and where risk-based advisory work can help.